FDA Approvals: Lumigan, Cesamet, Omnitrope

The FDA has approved an expanded indication for bimatoprost 0.03% ophthalmic solution (Lumigan); nabilone 1-mg capsules (Cesamet); and a recombinant DNA follow-on formulation of somatropin (Omnitrope).Yael Waknine

Continue to FDA Approvals: Lumigan, Cesamet, Omnitrope on Medscape Medical News Headlines.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz